Quantcast

Latest Tuberculosis treatment Stories

2014-08-21 16:24:42

NEW YORK, Aug. 21, 2014 /PRNewswire/ -- Bruckner Oncology has initiated an FDA approved Phase II-III clinical trial which adds Vitamin C to chemotherapy "core" regimens (GFLIO and GFLIO-D) for patients with locally advanced and metastatic pancreatic cancer (APC). Vitamin C was selected for study because there has never been a formal clinical trial of this frequently used, off label vitamin which has long been credited with improving safety and quality of life during chemotherapy....

2014-07-31 08:37:14

Brock Will Lead Resource Development, Advocacy, Community Engagement Efforts in Support of Promising Research Pipeline NEW YORK, July 31, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit with the mission of discovering and developing better, faster and affordable treatments, announced the appointment of Willo Brock as Senior Vice President, External Affairs. Mr. Brock comes to TB Alliance having most recently served as Head of Major Donor Relations for WWF...

2014-07-31 08:37:08

Robertson Will Lead Initiatives to Accelerate Adoption of New TB Drug Regimens NEW YORK, July 31, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization with the mission of developing better, faster and affordable treatments for tuberculosis (TB), announced the appointment of Elana Robertson to Senior Vice President, Market Access. Ms. Robertson joins the organization from Novartis Vaccines, where she was responsible for the company's business in Sub-Saharan...

2014-06-28 12:09:52

St. Michael's Hospital More screening may be needed Tuberculosis infection among people taking corticosteroid pills may be underestimated, new research suggests. Current guidelines for what constitutes a positive TB skin test among corticosteroid pill users may not be capturing all those who are infected, said Dr. Nicholas Vozoris, a respirologist in the Tuberculosis Program at St. Michael's Hospital. Previous research has shown that people who take corticosteroid pills, such as...

2014-05-14 08:32:24

Fotouhi to guide organization's discovery-stage research and clinical trials of drug candidates NEW YORK, May 14, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization dedicated to developing better, faster, and affordable treatments for tuberculosis (TB), announced the appointment of Nader Fotouhi, Ph.D. as Chief Scientific Officer. Nader comes to the TB Alliance with nearly 25 years of experience, having served most recently as Vice President & Global Head...

2014-04-23 16:29:42

Partnership Supports Newly Announced STAND Trial SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) drugs, has announced that it is collaborating with, and has granted an exclusive license to, the Shanghai Fosun Pharmaceutical Development Co., Ltd., and its subsidiary Shenyang Hongqi Pharmaceutical Co., Ltd. (Fosun Pharma), to develop and...

2014-04-23 16:29:39

STAND trial will test the first regimen designed to significantly shorten and simplify the treatment of drug-sensitive and drug-resistant TB SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both drug-sensitive and some forms of multi-drug resistant tuberculosis (TB) to a global Phase 3 clinical trial. The announcement by Bill Gates, co-chair of the Bill...

2014-04-02 23:32:49

Presentation details three separate tuberculosis immunotherapies developed by Immunitor in collaboration with academic institutions and private companies in Mongolia, China, Thailand, Ukraine, UK, USA and Canada. Data presented support the Immunitor strategy to target inflammation as the main cause of TB and development of immunomodulators and therapeutic vaccines which demonstrate ability to rapidly clear TB, including MDR-TB and TB with HIV. Vancouver, BC, Canada (PRWEB) April 02, 2014...

2014-03-24 12:29:49

IBM's Big Data analytics to help crack the code of the tuberculosis genome and uncover new diagnosis and treatment approaches DURBAN, South Africa, March 24, 2014 /PRNewswire/ -- On World Tuberculosis Day, IBM (NYSE:IBM) and the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) have announced plans to research new treatment approaches to fight tuberculosis (TB) in South Africa. IBM's Big Data analytics technologies will be put to work on bacterial genetics and drug...

Bringing Attention To The Threat Of Tuberculosis On World TB Day
2014-03-24 07:49:51

Lawrence LeBlond for redOrbit.com - Your Universe Online Global partnerships and significant medical research are a big part of this year’s World Tuberculosis Day. Celebrated each year on March 24, World TB Day is a marked as a time to bring attention to the threat of tuberculosis, a disease that affects nearly nine million people a year. WHO For the World Health Organization (WHO), this year’s slogan for World TB Day is “Reach 3 Million.” Despite TB’s curability, efforts...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.